Zynex Medical (ZYXI): Market Cap to Revenue

Symbol and logo of brand Zynex Medical (ZYXI)

Zynex, Inc. (ZYXI) is scaling sales of home electrostimulation, offering a safe alternative to opioids through an extensive physician network. The divergence of the P/S ratio from its historical average reflects the dynamics of the business's market valuation, where the current parameter is 0.00. Growth is constrained by the complexity of insurance reimbursements and stringent FDA requirements, which create significant barriers to entry for competitors in the pain therapy segment.

ZYXI Zynex Medical P/S Multiple (07/04/2022 - 01/03/2026)

Analytical breakdowns for zynex.com (ZYXI)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:ZYXI Zynex Medical
Core merchandise of Zynex, Inc.

Zynex, Inc. (ZYXI) is strengthening its market position by diversifying medical systems for home and inpatient pain management. The P/S multiple compares the business's market value to its annual revenue, determining the cost of one dollar of sales. Investors utilize this balance to assess whether the asset is overbought and to analyze the liquidity of large positions. This price action is clearly reflected through the historical P/S value of Zynex, Inc. (ZYXI).

Competitors of Zynex, Inc.

DXCM (DexCom Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple PEN (penumbrainc.com)|NOVT - Market Cap to Revenue|Haemonetics - P/S Multiple|Price to Sales Inspire Medical Systems|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Medical) - P/S Multiple|InMode Corp (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics, Inc. SRDX|P/S Multiple SENS (senseonics.com)|P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|Outset Medical Corp (OM) - Price-to-Revenue Ratio|SmartVest - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR Inc) - P/S Multiple|Price to Sales AVITA Medical Inc. RCEL|Price-to-Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Price-to-Revenue Multiple|EDAP TMS SA - Market Cap to Revenue|P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx LUNG|TELA Bio (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corp.)|Price-to-Revenue Ratio sensushealthcare.com|Market Cap to Revenue electroCore, Inc. (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|SeaStar Medical - Market Cap to Revenue|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|beyondair.net - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|SSKN - Price-to-Revenue Coefficient|Price-to-Revenue Ratio GlucoTrack|P/S Multiple NanoVibronix Inc.|Price-to-Revenue Ratio Venus Concept (VERO)|Market Cap to Revenue Nuwellis, Inc. NUWE|P/S Multiple AEMD (Aethlon Medical, Inc.)|ASXC: Market Cap to Revenue Ratio|Avinger Inc. - P/S Multiple|Price-to-Revenue Coefficient BioSig Technologies, Inc BSGM|CUTR: P/S Multiple|Know Labs, Inc. (KNW) - P/S Multiple|Price-to-Revenue Ratio Inari Medical Inc|Market Cap to Revenue Nevro Corp (NVRO)|Market Cap to Revenue RSLS (ReShape Lifesciences, Inc.)|P/S Multiple Silk Road Medical Inc. (SILK)